1. 1672PMaintenance treatment with the TLR9 agonist lefitolimod in extensive-stage small-cell lung cancer (ES-SCLC): Final results from the randomized phase II IMPULSE study. (23rd October 2018) Authors: Thomas, M; Ponce Aix, S; Navarro Mendivil, A; Riera Knorrenschild, J; Schmidt, M; Wiegert, E; Kapp, K; Mauri, C; Domine Gomez, M; Kollmeier, J; Sadjadian, P; Fröhling, K-P; Huber, R M; Wolf, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗